{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:01:38Z","timestamp":1790240498456,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sponsorship: Almirall, S.A., Barcelona, Catalonia (Spain)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord Ser Cases"],"DOI":"10.1038\/s41394-025-00712-2","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T16:57:29Z","timestamp":1752771449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effects of nabiximols (Sativex\u00ae) on spasticity and non-motor symptoms in chronic spinal cord injury (SCI): a longitudinal prospective study"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8355-4457","authenticated-orcid":false,"given":"Fernando","family":"Martins Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-4208","authenticated-orcid":false,"given":"Sergiu","family":"Albu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mari\u00f1o Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mart\u00ednez Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-1808","authenticated-orcid":false,"given":"Jes\u00fas","family":"Benito-Penalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Vidal Sams\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"712_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000057154","volume":"6","author":"M Schnelle","year":"1999","unstructured":"Schnelle M, Grotenhermen F, Reif M, Gorter RW. Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabisprodukten im deutschen Sprachraum. Complement Med Res. 1999;6:28\u201336.","journal-title":"Complement Med Res"},{"key":"712_CR2","unstructured":"Grotenhermen F, Reckendrees B Die Behandlung mit Cannabis und THC: medizinische M\u00f6glichkeiten, rechtliche Lage, Rezepte, Praxistipps. 6., erweiterte Neuauflage. Solothurn: Nachtschatten Verlag; 2016. 105 p."},{"key":"712_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","volume":"160","author":"V Chiurchi\u00f9","year":"2018","unstructured":"Chiurchi\u00f9 V, Van Der Stelt M, Centonze D, Maccarrone M. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases. Progress Neurobiol. 2018;160:82\u2013100.","journal-title":"Progress Neurobiol"},{"key":"712_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou S, Kumar U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International J Mol Sci. 2018;19:833.","journal-title":"International J Mol Sci"},{"key":"712_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","volume":"18","author":"D Friedman","year":"2019","unstructured":"Friedman D, French JA, Maccarrone M. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol. 2019;18:504\u201312.","journal-title":"Lancet Neurol"},{"key":"712_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fncel.2020.00034","volume":"14","author":"M Mecha","year":"2020","unstructured":"Mecha M, Carrillo-Salinas FJ, Feli\u00fa A, Mestre L, Guaza C. Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review. Front Cell Neurosci. 2020;14:34.","journal-title":"Front Cell Neurosci"},{"key":"712_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","volume":"18","author":"M Serpell","year":"2014","unstructured":"Serpell M, Ratcliffe S, Hovorka J, Schofield M, Taylor L, Lauder H, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014;18:999\u20131012.","journal-title":"Eur J Pain"},{"key":"712_CR8","doi-asserted-by":"crossref","unstructured":"Grotenhermen F, M\u00fcller-Vahl K The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches \u00c4rzteblatt international [Internet]. 2012 Jul 23 [cited 2024 May 27]; Available from: https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2012.0495.","DOI":"10.3238\/arztebl.2012.0495"},{"key":"712_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0028-1083094","volume":"43","author":"M Karst","year":"2008","unstructured":"Karst M, Bernateck M. Schmerzlinderung durch Cannabinoide? Bedeutung des Endocannabinoid systems und der Cannabinoide f\u00fcr die Schmerztherapie. An\u00e4sthesiol Intensivmed Notfallmed Schmerzther. 2008;43:522\u20138.","journal-title":"An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"},{"key":"712_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jemermed.2012.07.061","volume":"44","author":"CR Harris","year":"2013","unstructured":"Harris CR, Brown A. Synthetic Cannabinoid Intoxication: A Case Series and Review. Journal Emerg Med. 2013;44:360\u20136.","journal-title":"Journal Emerg Med"},{"key":"712_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/14740338.2011.575778","volume":"10","author":"P Robson","year":"2011","unstructured":"Robson P. Abuse potential and psychoactive effects of \u03b4-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Expert Opin Drug Saf. 2011;10:675\u201385.","journal-title":"Expert Opin Drug Saf"},{"key":"712_CR12","unstructured":"HERRERO R. Sanidad aprueba un derivado del cannabis para tratar la esclerosis m\u00faltiple [Internet]. El Correo. 2010 [cited 2024 May 27]. Available from: https:\/\/www.elcorreo.com\/vizcaya\/v\/20100729\/sociedad\/sanidad-aprueba-derivado-cannabis-20100729.html."},{"key":"712_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00541514","volume":"5","author":"GB Langley","year":"1985","unstructured":"Langley GB, Sheppeard H. The visual analogue scale: Its use in pain measurement. Rheumatol Int. 1985;5:145\u20138.","journal-title":"Rheumatol Int"},{"key":"712_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nur.4770130405","volume":"13","author":"ME Wewers","year":"1990","unstructured":"Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Research Nurs Health. 1990;13:227\u201336.","journal-title":"Research Nurs Health"},{"key":"712_CR15","unstructured":"Harb A, Kishner S Modified Ashworth Scale. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 3]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554572\/."},{"key":"712_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41393-018-0063-5","volume":"56","author":"PB Mills","year":"2018","unstructured":"Mills PB, Vakil AP, Phillips C, Kei L, Kwon BK. Intra-rater and inter-rater reliability of the Penn Spasm Frequency Scale in People with chronic traumatic spinal cord injury. Spinal Cord. 2018;56:569\u201374.","journal-title":"Spinal Cord"},{"key":"712_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41393-022-00807-9","volume":"60","author":"N Khamnon","year":"2022","unstructured":"Khamnon N, Amatachaya S, Wattanapan P, Musika N, Jitmongkolsri P, Kongngoen N, et al. Reliability and concurrent validity of the Spinal Cord Independence Measure III among rehabilitation professionals. Spinal Cord. 2022;60:875\u201381.","journal-title":"Spinal Cord"},{"key":"712_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248\u201357.","journal-title":"Pain"},{"key":"712_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"712_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"712_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"The Whoqol Group.","year":"1998","unstructured":"The Whoqol Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998;28:551\u20138.","journal-title":"Psychol Med"},{"key":"712_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02190083","volume":"240","author":"M Maurer","year":"1990","unstructured":"Maurer M, Henn V, Dittrich A, Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Nuerosci. 1990;240:1\u20134.","journal-title":"Eur Arch Psychiatry Clin Nuerosci"},{"key":"712_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1191\/0269215503cr581oa","volume":"17","author":"DT Wade","year":"2003","unstructured":"Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 2003;17:21\u20139.","journal-title":"Clin Rehabil"},{"key":"712_CR24","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s10072-020-04413-6","volume":"41","author":"F Patti","year":"2020","unstructured":"Patti F, Chisari CG, Solaro C, Benedetti MD, Berra E, Bianco A, et al. Effects of THC\/CBD oromucosal spray onspasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study. Neurol Sci. 2020;41:2905\u201313.","journal-title":"Neurol Sci"},{"key":"712_CR25","doi-asserted-by":"crossref","unstructured":"Hagenbach U, Luz S, Ghafoor N, Berger JM, Grotenhermen F, Brenneisen R, et al. The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury. Spinal Cord. 2007;45:551\u201362.","DOI":"10.1038\/sj.sc.3101982"},{"key":"712_CR26","doi-asserted-by":"crossref","unstructured":"Pooyania S, Ethans K, Szturm T, Casey A, Perry D. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch Phys Med Rehabil. 2010;91:703\u20137.","DOI":"10.1016\/j.apmr.2009.12.025"},{"key":"712_CR27","doi-asserted-by":"crossref","unstructured":"Abood ME, Pertwee RG, editors. Cannabinoids. Berlin Heidelberg: Springer; 2005. 770 p. (Handbook of experimental pharmacology \/ ed. board G. V. R. Born).","DOI":"10.1007\/b137831"},{"key":"712_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jpain.2016.05.010","volume":"17","author":"B Wilsey","year":"2016","unstructured":"Wilsey B, Marcotte TD, Deutsch R, Zhao H, Prasad H, Phan A. An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. J Pain. 2016;17:982\u20131000.","journal-title":"J Pain"},{"key":"712_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/PHM.0b013e3181f1c4ec","volume":"89","author":"DH Rintala","year":"2010","unstructured":"Rintala DH, Fiess RN, Tan G, Holmes SA, Bruel BM. Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury: A Pilot Study. American J Phys Med Rehabilitation. 2010;89:840\u20138.","journal-title":"American J Phys Med Rehabilitation"},{"key":"712_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/ph16081079","volume":"16","author":"JS Hansen","year":"2023","unstructured":"Hansen JS, Gustavsen S, Roshanisefat H, Kant M, Biering-S\u00f8rensen F, Andersen C, et al. Cannabis-Based Medicine for Neuropathic Pain and Spasticity\u2014A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial. Pharmaceuticals. 2023;16:1079.","journal-title":"Pharmaceuticals"},{"key":"712_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41394-019-0227-3","volume":"5","author":"JA Bourke","year":"2019","unstructured":"Bourke JA, Catherwood VJ, Nunnerley JL, Martin RA, Levack WMM, Thompson BL, et al. Using cannabis for pain management after spinal cord injury: a qualitative study. Spinal Cord Ser Cases. 2019;5:82.","journal-title":"Spinal Cord Ser Cases"},{"key":"712_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/10790268.2020.1865709","volume":"45","author":"PA Thomas","year":"2022","unstructured":"Thomas PA, Carter GT, Bombardier CH. A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury. Journal Spinal Cord Med. 2022;45:656\u201367.","journal-title":"Journal Spinal Cord Med"},{"key":"712_CR33","doi-asserted-by":"crossref","unstructured":"Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O. et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols *(Sativex(\u00ae)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol. 2011;18:1122\u201331.","DOI":"10.1111\/j.1468-1331.2010.03328.x"},{"key":"712_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/nmt-2017-0055","volume":"8","author":"J Mallada Frech\u00edn","year":"2018","unstructured":"Mallada Frech\u00edn J. Effect of Tetrahydrocannabinol:Cannabidiol Oromucosal Spray on Activities of Daily Living in Multiple Sclerosis Patients with Resistant Spasticity: A retrospective, Observational Study. Neurodegener Dis Manag. 2018;8:151\u20139.","journal-title":"Neurodegener Dis Manag"},{"key":"712_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.sc.3102149","volume":"46","author":"S Villan","year":"2008","unstructured":"Villan S. Use of \u03949-tetrahydrocannabinol in the treatment of spasticity in spinal cord injury patients. Spinal Cord. 2008;46:460\u2013460.","journal-title":"Spinal Cord"}],"container-title":["Spinal Cord Series and Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41394-025-00712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-025-00712-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-025-00712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:33:29Z","timestamp":1757252009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41394-025-00712-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1038\/s41394-025-00712-2","relation":{},"ISSN":["2058-6124"],"issn-type":[{"value":"2058-6124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethics approval was obtained from the Ethics Committee for Research with Medicinal Products (CEIm) of the Fundaci\u00f3 Uni\u00f3 Catalana d\u2019Hospitals, by resolution dated 18 April 2023. This study is registered in the EudraCT database under number 2022-001777-31. Written informed consent was obtained from all participants prior to participation. No identifiable images or personal data of participants are included in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"19"}}